SCHEMBL24310171

SCHEMBL24310171

Cc1ccccc1-c1nc(NSc2cnn(C)c2)nc(Oc2ccc(N3CCN(C)CC3)cc2)c1C(C)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSC P53634 2/20 0.36
▸ MAP4K1 Q92918 1/20 0.36
▸ PDE2A O00408 1/20 0.36
▸ PDE10A Q9Y233 1/20 0.36
▸ ITK Q08881 1/20 0.34
▸ IGF1R P08069 1/20 0.33
▸ HRH4 Q9H3N8 2/20 0.33
▸ TTK P33981 1/20 0.33
▸ TACR1 P25103 1/20 0.33
▸ MAP3K7 O43318 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ MAP2K1 Q02750 1/20 0.32
▸ JAK2 O60674 1/20 0.32
▸ JAK1 P23458 1/20 0.32
▸ TYK2 P29597 1/20 0.32
▸ STAT3 P40763 1/20 0.32
▸ JAK3 P52333 1/20 0.32
▸ TNK2 Q07912 1/20 0.32
▸ CCNK O75909 1/20 0.32
▸ CCNA2 P20248 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310158 0.94 MAP4K1 (0.37) CTSCMAP4K1PDE2APDE10AITK
SCHEMBL24310428 0.90 MAP4K1 (0.38) CTSCMAP4K1PDE2APDE10AITK
SCHEMBL24309719 0.88 MAP4K1 (0.37) CTSCMAP4K1PDE2APDE10AITK
SCHEMBL24310424 0.88 PDE2A (0.41) CTSCMAP4K1PDE2APDE10AITK
SCHEMBL24310201 0.88 MAP4K1 (0.32) MAP4K1IGF1R
SCHEMBL24309843 0.87 CTSC (0.41) CTSCMAP4K1IGF1RHRH4TACR1
SCHEMBL24309882 0.87 MAP4K1 (0.37) CTSCMAP4K1PDE2APDE10AITK
SCHEMBL24309386 0.86 JAK2 (0.37) CTSCMAP4K1PDE2APDE10AITK
SCHEMBL24310153 0.86 CTSC (0.36) CTSCMAP4K1IGF1RHRH4JAK2
SCHEMBL24309392 0.85 BRD4 (0.37) CTSCMAP4K1PDE2APDE10AITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback